SYNKRINO BIOTHERAPEUTICS

Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients. The platform is providing monitoring for pediatric rheumatologists for life-threatening conditions. It is currently building a rapid, portable field test for the RNA virus 2019-nCoV/COVID-19, adapting its existing analytic protocols for community public health screening. Synkrino Biotherapeutics' therapeutics use AI + Immunology Discovery Engine (AIDE Engine) which applies neural networks and machine learning to measure the immune tissue from patients to repeatably discover novel and biologically-valid drug targets, enabling healthcare providers to cure their patients and improve their lives.

#People #Financial #Website #More

SYNKRINO BIOTHERAPEUTICS

Industry:

Artificial Intelligence Biotechnology Health Care Therapeutics

Founded:

2018-01-01

Address:

Berkeley, California, United States

Country:

United States

Website Url:

http://www.synkrino.bio

Total Employee:

1+

Status:

Active

Total Funding:

0

Technology used in webpage:

IPv6 Google Apps For Business Cloudflare Hosting Cloudflare DNS Webflow

Current Employees Featured

not_available_image

Jason Barbour
Jason Barbour Co-Founder and CEO @ Synkrino Biotherapeutics
Co-Founder and CEO

not_available_image

David Ott
David Ott CTO and Co-Founder @ Synkrino Biotherapeutics
CTO and Co-Founder

Founder

not_available_image

David Ott

not_available_image

Jason Barbour

Investors List

endpoint-ventures_image

Endpoint Ventures

Endpoint Ventures investment in Seed Round - Synkrino Biotherapeutics

y-combinator_image

Y Combinator

Y Combinator investment in Seed Round - Synkrino Biotherapeutics

Official Site Inspections

http://www.synkrino.bio

Host Informations
Whois Informations

Loading ...

More informations about "Synkrino Biotherapeutics" on Search Engine